Furthermore, HMX2 activity was detected in 4/31 (12.9%) AML cell lines including EOL-1, MOLM-13 and MV4-11 (GSE59808), all of which carry KMT2A aberrations, coinciding with the picture in patient samples (S1E Fig). This evidence concerns the gene HMX2 and acute myeloid leukemia.